CTOs on the Move

MacuLogix

www.maculogix.com

 
MacuLogix is the only company to leverage the science of dark adaptation to help eliminate preventable blindness caused by AMD.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.maculogix.com
  • 1801 Oberlin Road Suite 301
    Middletown, PA USA 17057
  • Phone: 717.914.4067

Executives

Name Title Contact Details

Funding

MacuLogix raised $10M on 07/18/2018
MacuLogix raised $38.7M on 03/04/2019

Similar Companies

Franciscan Health System West

Franciscan Health System West is a Tacoma, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Immedica

Immedica is a Chatham, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

O'Hara Technologies

O'Hara Technologies Inc. is a Richmond Hill, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Musculoskeletal Clinical Regulatory Advisers

MCRA is the leading global full-service medical device, diagnostics, and biologics CRO and consulting advisory firm. MCRA delivers to its client`s industry experience, integrating its six business value creators: regulatory, clinical research, reimbursement, healthcare compliance, quality assurance, and distribution logistics to provide a dynamic, market-leading effort from innovation conception to commercialization. MCRA`s integrated application of these key value-creating initiatives provides unparalleled value for its clients. MCRA has offices in Washington, DC, Hartford, CT, New York, NY, and Tokyo, Japan and serves nearly 1,000 clients globally. Its core focus areas of therapeutic experience include orthopedics, spine, biologics, cardiovascular, diagnostic imaging, wound care, artificial intelligence, dental, anesthesia, general surgery, digital health, neurology, robotics, oncology, general and plastic surgery, urology, and in vitro diagnostic (IVD) devices and medical device cybersecurity. MCRA places particular emphasis on its expertise working with companies in all stages of development and throughout the technology life cycle by ushering technologies from the conceptual pre-clinical stage to market approval.

Bioventus

Bioventus®Inc. (Nasdaq: BVS) develops Innovations for Active Healing and its mission is to make a difference by helping patients resume and enjoy active lives. The Company has products for pain treatment & joint preservation, restorative therapies and bone graft substitutes. Established in 2012, Bioventus is headquartered in Durham, NC. The company has more than 800 employees worldwide and its international headquarters is in Hoofddorp, The Netherlands. Bioventus also has offices in Memphis, TN, Valencia, CA, Hod Hasharon, Israel and Mississauga, Ontario, Canada. Bioventus works with patients, payers and health care providers throughout the world.